With the COVID-19 infection cases in Egypt starting to decrease and many people starting to embrace a more relaxed lifestyle closer to what existed before the outbreak, some are starting to wonder when a vaccine will finally be able to stabilize the “new normal” that the world is currently experiencing. According to the New York Times’ Coronavirus Vaccine Tracker, there has been one vaccine so far that has been approved for limited use. That vaccine is developed by a Chinese company called CanSino Biologics who reported in July that their Phase 2 trials’ vaccine produced a strong immune response. CanSino is in discussions with multiple countries including Russia, Brazil, Chile and Saudi Arabia to launch a large-scale phase three trial testing it, recruiting 40,000 participants to the study, Reuters reported. However, despite the success thus far, Head of the World Health Organization Tedros Adhanom Ghebreyesus told news briefings that though a number of vaccines are now in phase three clinical trials, a complete solution has not yet been achieved, according to BBC. ”We all hope to have a number of effective vaccines that can help prevent people from infection, however,…
